What you need to know about GB virus C

Current Gastroenterology Reports

Volumn 7, Issue 1, 2005, Pages 54-62

  George, Sarah L ^a   Varmaz, Dino ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

AIDS RELATED COMPLEX; FEMALE; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; LIVER FUNCTION TEST; MALE; METHODOLOGY; PATHOGENICITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SURVIVAL; VIRUS HEPATITIS; VIRUS INFECTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; LIVER FUNCTION TESTS; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 20444376330     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-005-0067-0     Document Type: Review

References (54)

1. Alter HJ: G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997, 37: 569-572.
2. Leary TP; Muerhoff AS, Simons JN, et al.: Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996, 48: 60-67.
3. Linnen J, Wages J, Zhang-Keck Z-Y, et al.: Molecular cloning and disease association of hepatitis G virus: A transfusiontransmissible agent. Science 1996, 271: 505-508.
4. Simons JN, Leary TP, Dawson GJ, et al.: Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995, 1: 564-569.
5. George SL, Wunschmann S, McCoy J, et al.: Interactions between GB virus type C and HIV. Curr Infect Dis Rep 2002, 4: 550-558. This paper summarizes the early literature on GBV-C and HIV infection and reviews the evidence for the nonpathogenic nature of GBV-C infection.
6. Dickens T, Lemon SM: GB Virus C, hepatitis G virus, or human orphan flavivirus? Hepatology 1997, 25: 1285-1286.
7. Alter HJ, Nakatsuji Y, Melpolder J, et al.: The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997, 336: 747-754.
8. Okamoto H, Nakao H, Inoue T et al.: The entire nucleotide sequence of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol 1997, 78: 737-745.
9. Xiang J, Klinzman D, McLinden J, et al.: Characterization of hepatitis G virus (GB-C Virus) particles: Evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 1998, 72: 2738-2744.
10. Kato T, Mizokami M, Nakano T, et al.: Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus. J Med Virol 2003, 55: 109-117.
11. Shao L, Shinzawa H, Zhang X, et al.: Diversity of hepatitis G virus within a single infected individual. Virus Genes 2000, 21: 215-221.
12. Naito H, Abe K: Genotyping system of GBV-C/HGV type 1 to type 4 by the polymerase chain reaction using type-specific primers and geographical distribution of viral genotypes. J Virol Methods 2001, 91: 3-9.
13. Muerhoff AS, Smith DB, Leary TP, et al.: Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. J Virol 1997, 71: 6501-6508.
14. Bukh J, Miller R, Purcell R: Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995, 15: 41-63.
15. Simmonds P, Holmes EC, Cha TA, et al.: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993, 74: 2391-2399.
16. Smith DB, Cuceanu N, Davidson F, et al.: Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5′ non-coding region. J Gen Virol 1997, 78: 1533-1542.
17. Halasz R, Sallberg M, Lundholm S, et al.: The GB virus C/hepatitis G virus replicates in hepatocytes without causing liver disease in healthy blood donors. J Infect Dis 2000, 182: 1756-1760.
18. Laskus T, Radkowski M, Wang LF, et al.: Detection of hepatitis G virus replication sites by using highly strand-specific Tthbased reverse transcriptase PCR. J Virol 1998, 72: 3072-3075.
19. Mellor J, Haydon G, Blair C, et al.: Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J GenVirol 1998, 79: 705-714.
20. Pessoa MG, Terrault NA, Detmer J, et al.: Quantitation of hepatitis G and C viruses in the liver: Evidence that hepatitis G virus is not hepatotropic. Hepatology 1998, 27: 877-880.
21. Chang M, Williams O, Mittler J et al.: Dynamics of hepatitis C virus replication in human liver. Am J Pathol 2003, 163: 433-444.
22. Terrault NA, Dailey PJ, Ferrell L, et al.: Hepatitis C virus: quantitation and distribution in liver. J Med Virol 1997, 51: 217-224.
23. Kobayashi M, Tanaka E, Nakayama J, et al.: Detection of GB virus-C/ hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue. J Med Virol 1999, 57: 114-121.
24. Xiang J, Wünschmann S, Schmidt WN, et al.: Full-length GB Virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 2000, 74: 9125-9133.
25. Radkowski M, Kubicka J, Kisiel E, et al.: Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood 2000, 95: 3986-3989.
26. Tucker TJ, Smuts HE, Eedes C, et al.: Evidence that the GBV-C/hepatitis C virus is primarily a lymphotropic virus. J Med Virol 2000, 61: 52-58.
27. Radkowski M, Wang LF, Cianciara J, et al.: Analysis of hepatitis G virus/ GB virus C quasispecies and replication sites in human subjects. Biochem Biophys Res Commun 1999, 258: 296-299.
28. Lefrere JJ, Ferec C, Roudot-Thoraval F, et al.: GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals. J Med Virol 1999, 59: 32-37.
29. Tillmann HL, Heiken H, Knapik-Botor A, et al.: Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001, 345: 715-724.
30. George SL, Xiang J, Stapleton JT: Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 2003, 316: 191-201.
31. Bourlet T, Guglielminotti C, Evrard M, et al.: Prevalence of GBV-C/ hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure. J Med Virol 1999, 58: 373-377.
32. Thomas DL, Vlahov D, Alter HJ, et al.: 1998. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998, 177: 539-542.
33. Klinzman D, Katz L, George SL, et al.: GBV-C prevalence in different populations suggests increased clearance with parenteral transmission. In Viral Hepatitis and Liver Disease. Sydney: 2004; in press.
34. Orii K, Tanaka E, Rokuhara A, et al.: Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus. Intervirology 2000, 43: 139-145.
35. Tillmann HL, Heringlake S, Trauwein C, et al.: Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 1998, 28: 379-384.
36. Williams CM, Klinzman D, Yamashita TE, et al.: Persistent GB virus type C infection and survival in HIV-infected men. N Engl J Med 2004, 350: 981-990. This is the most thorough, best controlled study to date of the influence of GBV-C infection on the course of HIV disease.
37. Yeo AET, Matsumoto A, Hisada M, et al.: Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Ann Intern Med 2000, 132: 959-963.
38. Chan KJ, Dong WWY, et al.: No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. AIDS 2002, 16: 1929-1933.
39. Birk M, Lindback S, Lidman C: No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002, 16: 2482-2485.
40. Xiang J, Wünschmann S, Diekema DJ et al.: Effect of coinfection with GB virus C (hepatitis G virus) on survival among patients with HIV infection. N Engl J Med 2001, 345: 707-714.
41. Weintrob AC, Hamilton JD, Hahn C, et al.: Active or prior GB virus C infection does not protect against vertical transmission of HIV in coinfected women from Tanzania. Clin Infect Dis 2004, 38: E46-e48.
42. Xiang J, McLinden JH, Chang Q, et al.: The GB Virus C envelope glycoprotein E2 induces broadly reactive HIV neutralizing antibodies. Presented at the 11th International Conference on Hepatitis C and Related Flaviviruses. Heidelberg, Germany. October 3-7, 2004.
43. Xiang J, George SL, Wunschmann S, et al.: GB virus C infection inhibits HIV-1 replication by increasing RANTES, MIP-1a, MIP-1b, and SDF-1. Lancet 2004, 363: 2040-2046. The first paper to evaluate the mechanism of inhibition by HIV replication by GBV-C.
44. Majumder M, Ghosh AK, Steele R, et al.: Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology 2002, 294: 95-105.
45. Nunnari G, Nigro L, Palermo F, et al.: Slower progression of HIV-1-infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003, 139: 26-30.
46. Nattermann J, Nischalke HD, Kupfer B, et al.: Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003, 17: 1457-1462.
47. Miyasaka Y, Enomoto N, Kurosaki M, et al.: Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factoralpha-mediated apoptosis in Huh 7 cells. J Infect Dis 2003, 188, 1537-1544.
48. George, SL, Varmaz D, Stapleton JT: GB virus C inhibits apoptosis in PBMCs. Presented at the 11th International Conference on Hepatitis C and Related Flaviviruses. Heidelberg, Germany. October 3-7, 2004.
49. Toyoda H, Fukuda Y, Hayakawa T, et al.: Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr 1998, 17: 209-213.
50. Heringlake S, Ockenga J, Tillmann HL, et al.: GB Virus C/Hepatitis G Virus infection: A favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998, 177: 1723-1726.
51. Lefr'ere JJ, Roudot-Thoraval F, Morand-Joubert L, et al.: Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999, 179: 783-789.
52. Rodriguez B, Woolley I, Lederman MM: Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients. J Infect Dis 2003, 187: 504-507.
53. Bjorkman P, Flamholc L, Naucler A, et al.: GB virus C during the natural course of HIV-1 infection: Viremia at diagnosis does not predict mortality. AIDS 2004, 18: 877-886.
54. Fields BN, Howley PM, Griffin DE, et al.: Field's Virology, vol 1. Philadelphia: Lippincott, Williams, & Wilkins; 2001:992.